[3919] in Athena User Interface
Major news release for this Co. Watch tomorrow
daemon@ATHENA.MIT.EDU (Quentin Ellis)
Tue Aug 23 23:26:22 2005
Message-ID: <015401c5a85b$8f102f20$8bf4bd50@FCWQZWV>
From: "Quentin Ellis" <M1ri1@eure.de>
To: <dough@mit.edu>
Date: Wed, 24 Aug 2005 00:23:45 -0500
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="----=_NextPart_000_0151_01C5A83A.07FE8F20"
This is a multi-part message in MIME format.
------=_NextPart_000_0151_01C5A83A.07FE8F20
Content-Type: text/plain;
charset="iso-8859-1"
Content-Transfer-Encoding: 7Bit
***MOMENTUM ALERT ISSUED** FOR WEDNESDAY AUG 24rd****
WORLDWIDE BIOTECH & PHARMACEUTICAL CO MAKES MAJOR MOVE 2 DAYS IN A ROW !!!!
WEDNESDAY: We could see $1.00 or more
TUESDAY: CLIMBING AGAIN up+ $0.70 (8.75%)
MONDAY: CLIMBING AMAZING up+ $2.50 (45.45%)
Symbol: WWBP
Price: $8.75
10 Day Target: $12-17
****You may not be aware of (WWBP), but you should be, because this company represents a terrific profit opportunity for early investors>
Worldwide Biotech and Pharmaceutical Company, a biotech company, engages in the development, manufacture, and marketing of diagnostic reagents. These diagnostic reagents include hepatitis C viruses, medicines, vaccines, and gene carriers. The company is based in Sarasota, Florida.
It is only a matter of time before it is released out into the investment community and they take it to the moon..
$ GET IN NOW!!! You know the old saying, buy the
rumor and sell on the news. Once the news is out it is time to get
ready for next rally...JUST DO YOURSELF A FAVOR AND WATCH WWBP again TUESDAY MORNING, and DON'T SAY WE DIDN'T TELL YOU..
****Make no mistake: Our mission at Hot-Stocks-Investors is to claw our way through the thousands of underperforming companies out there to find the golden needle in the haystack the micro-cap DIAMOND that can make you rich. More often than not, the stocks we profile show a significant increase in stock price as you can see with new IPO of WWBP. Sometimes this happens imediately like we saw Mon and Tue.
WE SEE BIG THINGS HAPPENING EVERYDAY, SO WE SAY KEEP YOUR EYE ON WWBP WEDNESDAY AND WATCH FOR A BIG MOVEMENT AGAIN !!!!!!
THIS IS AN ONLINE INTERNET IPO. IF YOU ARE RECEIVING THIS EMAIL, YOU ARE AMONG THE FIRST PUBLIC INVESTORS TO KNOW ABOUT WWBP !!!!WE SAY BUY LOW and TRADE HIGH
The following analysis of our results of operations and financial condition should be read in conjunction with the financial statements of Worldwide Biotech & Pharmaceutical Company for the year ended December 31, 2004 and notes thereto contained in Report on Form 10-KSB of Worldwide Biotech & Pharmaceutical Company as filed with the Securities and Exchange Commission.
The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Stock-based compensation expense increased to $780,000 for fiscal 2004 from $0 for fiscal 2003. The increase in stock-based compensation expense was attributable to the recording of stock-cash compensation in connection with the issuance of common stock options to employees for services rendered.
We record property and equipment at cost. Depreciation and amortization are provided using the straight-line method over the estimated economic lives of the assets, which are from five to ten years. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred.
------=_NextPart_000_0151_01C5A83A.07FE8F20
Content-Type: text/plain;;
charset="iso-8859-1"
Content-Transfer-Encoding: 7Bit
***MOMENTUM ALERT ISSUED** FOR WEDNESDAY AUG 24rd****
WORLDWIDE BIOTECH & PHARMACEUTICAL CO MAKES MAJOR MOVE 2 DAYS IN A ROW !!!!
WEDNESDAY: We could see $1.00 or more
TUESDAY: CLIMBING AGAIN up+ $0.70 (8.75%)
MONDAY: CLIMBING AMAZING up+ $2.50 (45.45%)
Symbol: WWBP
Price: $8.75
10 Day Target: $12-17
****You may not be aware of (WWBP), but you should be, because this company represents a terrific profit opportunity for early investors>
Worldwide Biotech and Pharmaceutical Company, a biotech company, engages in the development, manufacture, and marketing of diagnostic reagents. These diagnostic reagents include hepatitis C viruses, medicines, vaccines, and gene carriers. The company is based in Sarasota, Florida.
It is only a matter of time before it is released out into the investment community and they take it to the moon..
$ GET IN NOW!!! You know the old saying, buy the
rumor and sell on the news. Once the news is out it is time to get
ready for next rally...JUST DO YOURSELF A FAVOR AND WATCH WWBP again TUESDAY MORNING, and DON'T SAY WE DIDN'T TELL YOU..
****Make no mistake: Our mission at Hot-Stocks-Investors is to claw our way through the thousands of underperforming companies out there to find the golden needle in the haystack the micro-cap DIAMOND that can make you rich. More often than not, the stocks we profile show a significant increase in stock price as you can see with new IPO of WWBP. Sometimes this happens imediately like we saw Mon and Tue.
WE SEE BIG THINGS HAPPENING EVERYDAY, SO WE SAY KEEP YOUR EYE ON WWBP WEDNESDAY AND WATCH FOR A BIG MOVEMENT AGAIN !!!!!!
THIS IS AN ONLINE INTERNET IPO. IF YOU ARE RECEIVING THIS EMAIL, YOU ARE AMONG THE FIRST PUBLIC INVESTORS TO KNOW ABOUT WWBP !!!!WE SAY BUY LOW and TRADE HIGH
The following analysis of our results of operations and financial condition should be read in conjunction with the financial statements of Worldwide Biotech & Pharmaceutical Company for the year ended December 31, 2004 and notes thereto contained in Report on Form 10-KSB of Worldwide Biotech & Pharmaceutical Company as filed with the Securities and Exchange Commission.
The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Stock-based compensation expense increased to $780,000 for fiscal 2004 from $0 for fiscal 2003. The increase in stock-based compensation expense was attributable to the recording of stock-cash compensation in connection with the issuance of common stock options to employees for services rendered.
------=_NextPart_000_0151_01C5A83A.07FE8F20--
